Parkinson's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with Parkinson's disease (at an early to moderate stage), mild cognitive impairment (MCI), or subjective cognitive complaints (feeling your memory or thinking has gotten worse)
- You scored at or above a certain level on a standard memory and thinking test called the MoCA (confirm with trial site for exact score)
- You have had at least 5 years of education
- You are between 18 and 85 years old
- Italian is your first (native) language
- You do not have serious hearing or vision problems that cannot be corrected
- Your vision is normal, or can be corrected to normal with glasses or contact lenses
- You are willing to take part and have signed a consent form agreeing to join the study
- You have a family member, carer, or trusted person who can support you during the study
- You are not currently taking part in any rehabilitation programme, and have not done so in the last 3 months
- Any medication you take has been at a stable dose for at least the last 3 months
Who may not be able to join:
- You have a medical or mental health condition that could make it difficult to complete the study's tests and assessments
- You have a medical condition that means you cannot safely receive a brain stimulation treatment called TMS (transcranial magnetic stimulation) — for example, having a metal implant in your head (confirm with trial site for full details)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in global cognition as assessed by Montreal Cognitive Assessment (MoCA); Change in long-term episodic verbal memory as assessed by Free and Cued Selective Reminding Test (FCSRT)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.